Chronic Gout: To lower uric acid levels and prevent the formation of gout crystals. Hyperuricemia: Management of high uric acid levels in the blood.

Febuxostat works by blocking an enzyme called xanthine oxidase. This enzyme is responsible for converting hypoxanthine into xanthine, and then xanthine into uric acid. By inhibiting this enzyme, Febuxostat effectively reduces the production of uric acid in the body, which prevents the painful deposition of urate crystals in the joints.

Common: Liver function abnormalities, nausea, joint pain, and skin rashes. Gout Flares: Paradoxically, an increase in gout attacks can occur during the first few months of starting treatment as crystals shift. Serious: Cardiovascular events (heart attack or stroke) have been noted in some studies; immediate medical attention is required if chest pain or shortness of breath occurs.